National Health (Listed drugs on F1 or F2) Amendment Determination 2012 (No. 5) (No. PB 53 of 2012) (Cth)

Case

National Health (Listed drugs on F1 or F2) Amendment Determination 2012 (No. 5)

Instrument number PB 53 of 2012

National Health Act 1953

I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the


Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated              27            July   2012

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health and Ageing

Part 1         Preliminary

  1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2012 (No. 5).

(2)   This Determination may also be cited as PB 53 of 2012.

  1. Commencement

This Determination commences on 1 August 2012.

  1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Busulfan

Insert

Cabazitaxel 

[2]     Schedule 1, after item dealing with Hydromorphone

Omit

Hydroxychloroquine 

[3]     Schedule 1, after item dealing with Ibuprofen

Insert

Icatibant 

[4]     Schedule 1, after item dealing with Lacosamide

Omit

Lamivudine 

[5]     Schedule 1, after item dealing with Lapatinib

Omit

Latanoprost 

[6]     Schedule 1, after item dealing with Losartan

Insert

Mannitol 

[7]     Schedule 1, after item dealing with Posaconazole

Omit

Pramipexole 

[8]     Schedule 1, after item dealing with Ranibizumab

Insert

Rasagiline 

[9]     Schedule 1, after item dealing with Tiaprofenic acid

Insert

Ticagrelor 

[10]   Schedule 1, after item dealing with Tocilizumab

Omit

Topotecan 

[11]   Schedule 2, after item dealing with Hydroxocobalamin

Insert

Hydroxychloroquine 

[12]   Schedule 2, after item dealing with Lactulose

Insert

Lamivudine 

[13]   Schedule 2, after item dealing with Lansoprazole

Insert

Latanoprost

Latanoprost with timolol 

[14]   Schedule 2, after item dealing with Potassium chloride with potassium bicarbonate

Insert

Pramipexole

[15]   Schedule 2, after item dealing with Topiramate

Insert

Topotecan

Note

1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See

Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0